1/9
08:02 am
anik
Anika Therapeutics (NASDAQ:ANIK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $16.00 price target on the stock.
Low
Report
Anika Therapeutics (NASDAQ:ANIK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $16.00 price target on the stock.
1/9
07:58 am
anik
Rating for ANIK
Low
Report
Rating for ANIK
11/6
03:18 pm
anik
Rating for ANIK
Low
Report
Rating for ANIK